Rising Demand for ACE Inhibitors in Hypertension Treatment
The ACE Inhibitors Market has witnessed robust growth due to the increasing prevalence of hypertension worldwide. ACE inhibitors are considered a first-line therapy for managing high blood pressure by relaxing blood vessels and reducing workload on the heart. Their proven efficacy and relatively favorable safety profile have made them popular among physicians and patients alike.
Additionally, the expanding geriatric population with chronic cardiovascular conditions is further driving demand. Healthcare providers are focusing on early intervention to prevent complications such as stroke, heart failure, and kidney disease, which underscores the importance of ACE inhibitors in long-term disease management.